Beijing SL Pharmaceutical invested PnuVax and entered into high-end vaccine market

Search by Type

Report Charts News

Search by Company

Code Company name

Beijing SL Pharmaceutical invested PnuVax and entered into high-end vaccine market

Date:2011-09-08 Source:hangmeihangmei Text Size:

Beijing SL Pharmaceutical announced on 13th Aug, that it will invest RMB130 million to set up joint-venture PnuVax SL with Canadian company PnuVax Incorporated. SL Pharmaceutical and PnuVax will ho...

Welcome to our website. This service is open to member only.

Registration

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports

China Heparin Industry Report, 2010-20112011-09-28
China Blood Products Industry Report, 2010-20112011-09-05
China Monoclonal Antibody Industry Report, 2010-20112011-07-05
China Insulin Industry Report, 20102011-01-25
China Heparin Industry Report, 20102010-12-18
China Blood Products Industry Report, 20102010-11-10
Global and China Biopharmaceutical Industry Report, 20102010-09-16
China Blood Products Industry Report, 20092009-10-13